CBC Interpretation: Microcytic Hypochromic Anemia with Reactive Changes
This CBC demonstrates microcytic hypochromic anemia (MCV 60.7, MCH 19.0, Hgb 122) with compensatory erythrocytosis (RBC 6.4), accompanied by reactive leukocytosis and thrombocytosis, most consistent with either iron deficiency anemia or thalassemia trait, with the elevated WBC and platelets suggesting an underlying inflammatory or infectious process.
Primary Anemia Pattern Analysis
The core finding is microcytic hypochromic anemia with a paradoxically elevated RBC count:
- MCV 60.7 fL (markedly reduced) with MCH 19.0 pg (markedly reduced) indicates severe microcytosis and hypochromia 1
- Hemoglobin 122 g/L meets WHO criteria for anemia (below 130 g/L in men, below 120 g/L in non-pregnant women) 1
- Elevated RBC count (6.4) with low hemoglobin creates a characteristic pattern
Differential Diagnosis Priority
1. Thalassemia Trait (Most Likely)
The combination of marked microcytosis (MCV 60.7) disproportionate to the degree of anemia with elevated RBC count is the classic signature of thalassemia trait 1, 2. In thalassemia, the MCV is typically reduced out of proportion to the level of anemia, and patients maintain high RBC counts as a compensatory mechanism 1.
2. Iron Deficiency Anemia (Must Rule Out)
While possible, pure iron deficiency typically shows lower RBC counts with more pronounced anemia. However, the MCH is a more reliable marker than MCV for iron deficiency 1, and both are severely reduced here, so iron deficiency cannot be excluded without iron studies.
3. Combined Iron Deficiency + Thalassemia
The severe reduction in both MCV and MCH raises the possibility of coexistent iron deficiency in a thalassemia carrier 3. When these conditions overlap, hematological parameters (Hb, MCV, MCH, MCHC) are significantly more reduced than in either condition alone 3.
Reactive Hematologic Changes
The leukocytosis (WBC 17.8) with neutrophilia (73.9%) and thrombocytosis (Plt 411) represent reactive changes, not primary hematologic malignancy:
- These findings suggest an acute inflammatory or infectious process
- The monocytosis (6.3%) and eosinopenia (0.1%) further support an acute inflammatory state
- This reactive picture does NOT alter the primary diagnosis of microcytic anemia but may complicate interpretation of iron studies
Critical Caveat About Ferritin
Ferritin is an acute phase reactant 1. In the presence of inflammation (evidenced by your leukocytosis), a "normal" ferritin may mask true iron deficiency. The British Society of Gastroenterology guidelines state that ferritin <45 μg/L should raise suspicion for iron deficiency even with inflammation**, and **ferritin >150 μg/L makes absolute iron deficiency unlikely even with inflammation 1.
Immediate Diagnostic Algorithm
Step 1: Obtain serum ferritin immediately 1, 4
- If ferritin <15 μg/L: Iron deficiency confirmed (specificity 0.99) 1
- If ferritin 15-45 μg/L: Probable iron deficiency, especially with inflammation 1
- If ferritin >150 μg/L: Iron deficiency unlikely; proceed to Step 2 1
Step 2: If ferritin suggests iron deficiency is unlikely, obtain hemoglobin electrophoresis 1, 4
- This prevents unnecessary GI investigation in thalassemia carriers 1, 4
- Thalassemia trait shows elevated HbA2 levels (beta-thalassemia) or normal electrophoresis (alpha-thalassemia) 5
Step 3: Consider transferrin saturation if ferritin is equivocal 1
- Helps differentiate true iron deficiency from functional iron deficiency in inflammatory states 1
Step 4: Address the inflammatory/infectious process
- Identify and treat the cause of leukocytosis and thrombocytosis
- Repeat CBC after resolution to see if reactive changes normalize
Clinical Implications for Investigation
If iron deficiency is confirmed, investigation for GI blood loss is mandatory in post-menopausal women and all men 1, 4. The British Society of Gastroenterology recommends that investigation should be considered at any level of anemia in the presence of iron deficiency, with stronger indication for more severe anemia due to higher likelihood of serious GI pathology including malignancy 1.
If thalassemia trait is confirmed, no GI investigation is needed unless iron deficiency coexists 1, 4.
Common Pitfalls to Avoid
- Do not assume iron deficiency without checking ferritin - thalassemia trait is common and requires different management 1, 4
- Do not interpret ferritin in isolation - inflammation elevates ferritin, potentially masking iron deficiency 1
- Do not ignore the possibility of combined pathology - iron deficiency and thalassemia can coexist, producing more severe microcytosis 3
- Do not attribute everything to the reactive picture - the leukocytosis and thrombocytosis are secondary findings; the microcytic anemia requires specific investigation 5, 6